Global Information
회사소개 | 문의

신경계 인터벤션 기기 : 의료기기 파이프라인 평가

Interventional Neurology Devices - Medical Devices Pipeline Assessment, 2018

리서치사 GlobalData
발행일 2018년 06월 상품 코드 350913
페이지 정보 영문 306 Pages
가격
US $ 4,000 ₩ 4,573,600 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,000 ₩ 9,147,200 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 12,000 ₩ 13,720,800 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


신경계 인터벤션 기기 : 의료기기 파이프라인 평가 Interventional Neurology Devices - Medical Devices Pipeline Assessment, 2018
발행일 : 2018년 06월 페이지 정보 : 영문 306 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

세계 신경계 인터벤션(Interventional Neurology) 기기 시장의 주요 파이프라인 제품(의료기기)과 임상시험 진행 상황에 대해 조사했으며, 제품 특성 비교 분석(임상시험 진행단계별), 주요 기업 프로파일 및 대표적 제품, 최근의 시장 동향(자본거래 및 사업 제휴 등) 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 신경계 인터벤션 기기 시장 개요

제3장 신경계 인터벤션 기기 시장 : 임상시험중인 제품

  • 파이프라인 제품 : 임상시험 단계별
  • 파이프라인 제품 : 부문별
  • 파이프라인 제품 : 지역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 추정 인증시기별
  • 파이프라인 제품 : 현재 진행중인 임상시험

제4장 임상시험중인 파이프라인 제품 : 기업별

  • 신경계 인터벤션 기기 기업 : 임상시험 단계별 파이프라인 제품
  • 신경계 인터벤션 기기 : 임상시험 단계별 파이프라인 제품

제5장 신경계 인터벤션 기기 시장 : 기업 및 제품 개요

  • Alcyone Lifesciences Inc
  • Amnis Therapeutics Ltd
  • Anaconda BioMed SL
  • Aneuclose LLC
  • Apeliotus Technologies
  • Arterain Medical Inc (Inactive)
  • Avantec Vascular Corporation
  • BioCure, Inc.
  • Ceretrieve Ltd
  • Codman & Shurtleff Inc
  • Collagen Matrix Inc
  • Cordis Corp
  • CranioVation
  • CVTec Cerebrovascular Technologies GmbH
  • Dartmouth College
  • DePuy Synthes Inc
  • EchoGuide Medical, Inc. (Inactive)
  • Ecole Polytechnique Federale de Lausanne
  • Gaudi Vascular, Inc.
  • Hansen Medical Inc
  • Hansjorg Wyss Institute for Biologically Inspired Engineering
  • Hibernia Medical
  • Insera Therapeutics, LLC
  • InspireMD Inc
  • Medikit Co Ltd
  • Medtronic plc
  • Merlin MD Pte. Ltd.
  • Metactive Medical LLC
  • MicroPort Scientific Corp
  • MicroVention, Inc.
  • MindFrame Inc
  • MiVi Neuroscience, LLC
  • MRI Interventions Inc
  • NEOS Surgery SL
  • Neuravi Ltd
  • NeuroInterventional Therapeutics, Inc.
  • NeuroInterventions
  • Neurosigma Inc
  • Neurosyntec LLC. (Inactive)
  • NexGen Medical Systems Inc
  • NSVascular, Inc.
  • Oxford Endovascular Limited
  • Palmaz Scientific Inc
  • Penumbra Inc
  • Philips Healthcare
  • PhotoThera Inc (Inactive)
  • Pulsar Vascular, Inc.
  • Pulse Therapeutics Inc
  • Rapid Medical
  • Rontis AG
  • Shape Memory Therapeutics, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Strategic Polymer Sciences, Inc
  • Taewoong Medical Co Ltd
  • terumo Corp Company
  • Triticum Medical Ltd.
  • Twin Star Medical Inc
  • University of California Los Angeles
  • University of California San Francisco
  • University of Minnesota
  • University of South Florida
  • University of Wisconsin Madison
  • University of Wolverhampton
  • Valor Medical Inc
  • Vascular Solutions Inc
  • Viket Medical Corporation
  • Weill Cornell Medical College
  • Zoll Medical Corporation

제6장 신경계 인터벤션 기기 시장 : 최근 동향

제7장 부록

도표

LSH 17.05.30

List of Tables

1.1 List of Tables

  • Table 1: Interventional Neurology Devices - Pipeline Products by Stage of Development 17
  • Table 2: Interventional Neurology Devices - Pipeline Products by Segment 18
  • Table 3: Interventional Neurology Devices - Pipeline Products by Territory 19
  • Table 4: Interventional Neurology Devices - Pipeline Products by Regulatory Path 20
  • Table 5: Interventional Neurology Devices - Pipeline Products by Estimated Approval Date 21
  • Table 6: Interventional Neurology Devices - Ongoing Clinical Trials 22
  • Table 7: Interventional Neurology Devices Companies - Pipeline Products by Stage of Development 23
  • Table 8: Interventional Neurology Devices - Pipeline Products by Stage of Development 26
  • Table 9: Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 10: Alcyone Microcatheter - Product Status 29
  • Table 11: Alcyone Microcatheter - Product Description 29
  • Table 12: Amnis Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 13: Golden Retriever - Product Status 30
  • Table 14: Golden Retriever - Product Description 30
  • Table 15: Anaconda BioMed SL Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 16: ANCD BRAIN - Product Status 31
  • Table 17: ANCD BRAIN - Product Description 31
  • Table 18: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 19: Janjua Aneurysm Net - Product Status 32
  • Table 20: Janjua Aneurysm Net - Product Description 32
  • Table 21: Janjua Aneurysm Occlusion Saddle - Product Status 33
  • Table 22: Janjua Aneurysm Occlusion Saddle - Product Description 33
  • Table 23: Aneuvas Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 24: PPODA-QT - Product Status 34
  • Table 25: PPODA-QT - Product Description 34
  • Table 26: Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 27: Polymer Stent for Cerebral Aneurysms - Product Status 35
  • Table 28: Polymer Stent for Cerebral Aneurysms - Product Description 35
  • Table 29: Arterain Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 30: Catheter Based System - Product Status 36
  • Table 31: Catheter Based System - Product Description 36
  • Table 32: Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 33: Endovascular Embolization Device - Product Status 37
  • Table 34: Endovascular Embolization Device - Product Description 37
  • Table 35: Ischemic Stroke Therapy Device - Product Status 38
  • Table 36: Ischemic Stroke Therapy Device - Product Description 38
  • Table 37: Bendit Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 38: Bendit 2.0 - Product Status 39
  • Table 39: Bendit 2.0 - Product Description 39
  • Table 40: BioCure Inc Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 41: GelCoil - Product Status 40
  • Table 42: GelCoil - Product Description 40
  • Table 43: Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 44: Intracranial Multilayer Flow Modulator - Product Status 41
  • Table 45: Intracranial Multilayer Flow Modulator - Product Description 41
  • Table 46: Ceretrieve Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 47: Device - Ischemic Stroke - Product Status 42
  • Table 48: Device - Ischemic Stroke - Product Description 42
  • Table 49: Cerus Endovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 50: Contour Neurovascular System - Product Status 43
  • Table 51: Contour Neurovascular System - Product Description 43
  • Table 52: NEQSTENT Intra-Saccular Stent - Product Status 44
  • Table 53: NEQSTENT Intra-Saccular Stent - Product Description 44
  • Table 54: Cerus Endovascular Ltd - Ongoing Clinical Trials Overview 45
  • Table 55: Contour Neurovascular System - A Safety Study of the Contour Neurovascular System in Treating Unruptured Aneurysms 46
  • Table 56: Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 57: Covered Stent - Product Status 47
  • Table 58: Covered Stent - Product Description 47
  • Table 59: Flow Diverter - Product Status 47
  • Table 60: Flow Diverter - Product Description 48
  • Table 61: Next Generation Balloon Expandable Stent - Product Status 48
  • Table 62: Next Generation Balloon Expandable Stent - Product Description 48
  • Table 63: Occlusion Balloon - Product Status 49
  • Table 64: Occlusion Balloon - Product Description 49
  • Table 65: Self-Expanding Stent - Product Status 49
  • Table 66: Self-Expanding Stent - Product Description 49
  • Table 67: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 68: Collagen-based Coils - Product Status 50
  • Table 69: Collagen-based Coils - Product Description 50
  • Table 70: CranioVation Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 71: Brain Aneurysm Clip - Product Status 51
  • Table 72: Brain Aneurysm Clip - Product Description 51
  • Table 73: CVTec Cerebrovascular Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 74: CoilAlarm - Product Status 52
  • Table 75: CoilAlarm - Product Description 52
  • Table 76: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 77: Aneurysm Clip Applicator - Product Status 53
  • Table 78: Aneurysm Clip Applicator - Product Description 53
  • Table 79: Cerebral Aneurysm Clip - Product Status 54
  • Table 80: Cerebral Aneurysm Clip - Product Description 54
  • Table 81: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 82: Liquid Embolic System - Product Status 55
  • Table 83: Liquid Embolic System - Product Description 55
  • Table 84: EchoGuide Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 85: Ultrasound Catheter Navigation Device - Product Status 56
  • Table 86: Ultrasound Catheter Navigation Device - Product Description 56
  • Table 87: Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 88: e-Dura Implant - Product Status 57
  • Table 89: e-Dura Implant - Product Description 57
  • Table 90: Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 91: eCLIPs System - Product Status 58
  • Table 92: eCLIPs System - Product Description 58
  • Table 93: Evasc Medical Systems Corp - Ongoing Clinical Trials Overview 59
  • Table 94: eCLIPs System - A Multi-center Post Marketing Study Evaluating the Safety, Technical Feasibility, and Efficacy of the eCLIPs Family of Products for the Treatment of Bifurcation Intracranial Aneurysms 60
  • Table 95: Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 96: Intracranial Stent - Product Status 61
  • Table 97: Intracranial Stent - Product Description 61
  • Table 98: Hansen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 99: Magellan Robotic System - Neurological Procedures - Product Status 62
  • Table 100: Magellan Robotic System - Neurological Procedures - Product Description 62
  • Table 101: Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 102: Hybernia Safety Catheter - Neuroprotection - Product Status 63
  • Table 103: Hybernia Safety Catheter - Neuroprotection - Product Description 63
  • Table 104: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 105: SHELTER - Product Status 64
  • Table 106: SHELTER - Product Description 64
  • Table 107: InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 108: NGuard Neurovascular - Product Status 65
  • Table 109: NGuard Neurovascular - Product Description 65
  • Table 110: Instent SAS Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 111: Smart Guide - Product Status 66
  • Table 112: Smart Guide - Product Description 66
  • Table 113: Medikit Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 114: Aspirarecath - Product Status 67
  • Table 115: Aspirarecath - Product Description 67
  • Table 116: Axcelguide - Product Status 68
  • Table 117: Axcelguide - Product Description 68
  • Table 118: Cerulean G - Product Status 68
  • Table 119: Cerulean G - Product Description 69
  • Table 120: Slimguide - Product Status 69
  • Table 121: Slimguide - Product Description 69
  • Table 122: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 123: Artisse Intrasaccular Device - Product Status 70
  • Table 124: Artisse Intrasaccular Device - Product Description 70
  • Table 125: Lazarus Cover - Product Status 71
  • Table 126: Lazarus Cover - Product Description 71
  • Table 127: Medina Embolization Device - Product Status 71
  • Table 128: Medina Embolization Device - Product Description 72
  • Table 129: Pipeline Flex w/Shield - Surface Enhancement - Product Status 72
  • Table 130: Pipeline Flex w/Shield - Surface Enhancement - Product Description 72
  • Table 131: Medtronic plc - Ongoing Clinical Trials Overview 73
  • Table 132: Artisse Intrasaccular Device - ARTISSE Aneurysm Treatment Using Intrasaccular Flow Diversion with the ARTISSE Device 74
  • Table 133: Medina Embolization Device - Medina Embolization Device in Neurovascular Aneurysms Study - A Post Market Clinical Follow-up Study: The MEDINA Study 75
  • Table 134: Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 135: Next Generation Device For Cerebral Aneurysm - Product Status 76
  • Table 136: Next Generation Device For Cerebral Aneurysm - Product Description 76
  • Table 137: Metactive Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 138: Ballstent Microcatheter - Product Status 77
  • Table 139: Ballstent Microcatheter - Product Description 77
  • Table 140: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 141: Clot Retrieval Device - Product Status 78
  • Table 142: Clot Retrieval Device - Product Description 78
  • Table 143: Embolization Coils - Product Status 79
  • Table 144: Embolization Coils - Product Description 79
  • Table 145: Micro-Catheter - Product Status 79
  • Table 146: Micro-Catheter - Product Description 79
  • Table 147: Vertebral Artery Rapamycin Target Eluting Stent System - Product Status 80
  • Table 148: Vertebral Artery Rapamycin Target Eluting Stent System - Product Description 80
  • Table 149: MicroPort Scientific Corp - Ongoing Clinical Trials Overview 81
  • Table 150: Embolization Coils - Prospective, Randomized, Controlled, Open Label, All China, Multi-center, Registration Trial of the Microport Neurotech Coil Embolization System for the Treatment of Intracranial Aneurysms 82
  • Table 151: MicroVention Inc Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 152: Advanced Coil - Product Status 83
  • Table 153: Advanced Coil - Product Description 83
  • Table 154: Advanced WEB Aneurysm Embolization Device - Product Status 84
  • Table 155: Advanced WEB Aneurysm Embolization Device - Product Description 84
  • Table 156: Coated Stent - Product Status 84
  • Table 157: Coated Stent - Product Description 85
  • Table 158: ERIC Retrieval Device - Product Status 85
  • Table 159: ERIC Retrieval Device - Product Description 85
  • Table 160: FRED Flow-Diverting Stent - Product Status 86

List of Figures

1.2 List of Figures

  • Figure 1: Interventional Neurology Devices - Pipeline Products by Stage of Development 17
  • Figure 2: Interventional Neurology Devices - Pipeline Products by Segment 18
  • Figure 3: Interventional Neurology Devices - Pipeline Products by Territory 19
  • Figure 4: Interventional Neurology Devices - Pipeline Products by Regulatory Path 20
  • Figure 5: Interventional Neurology Devices - Pipeline Products by Estimated Approval Date 21
  • Figure 6: Interventional Neurology Devices - Ongoing Clinical Trials 22

영문목차

GlobalData's Medical Devices sector report, "Interventional Neurology Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Interventional Neurology Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interventional Neurology Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Interventional Neurology Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Interventional Neurology Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Interventional Neurology Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 8
  • 1.2 List of Figures 14

2 Introduction 15

  • 2.1 Interventional Neurology Devices Overview 15

3 Products under Development 16

  • 3.1 Interventional Neurology Devices - Pipeline Products by Stage of Development 16
  • 3.2 Interventional Neurology Devices - Pipeline Products by Segment 17
  • 3.3 Interventional Neurology Devices - Pipeline Products by Territory 18
  • 3.4 Interventional Neurology Devices - Pipeline Products by Regulatory Path 19
  • 3.5 Interventional Neurology Devices - Pipeline Products by Estimated Approval Date 20
  • 3.6 Interventional Neurology Devices - Ongoing Clinical Trials 21

4 Interventional Neurology Devices - Pipeline Products under Development by Companies 22

  • 4.1 Interventional Neurology Devices Companies - Pipeline Products by Stage of Development 22
  • 4.2 Interventional Neurology Devices - Pipeline Products by Stage of Development 25

5 Interventional Neurology Devices Companies and Product Overview 28

  • 5.1 Alcyone Lifesciences Inc Company Overview 28
  • 5.2 Amnis Therapeutics Ltd Company Overview 29
  • 5.3 Anaconda BioMed SL Company Overview 30
  • 5.4 Aneuclose LLC Company Overview 31
  • 5.5 Aneuvas Technologies Inc Company Overview 33
  • 5.6 Apeliotus Technologies Company Overview 34
  • 5.7 Arterain Medical Inc (Inactive) Company Overview 35
  • 5.8 Avantec Vascular Corp Company Overview 36
  • 5.9 Bendit Technologies Ltd Company Overview 38
  • 5.10 BioCure Inc Company Overview 39
  • 5.11 Cardiatis SA Company Overview 40
  • 5.12 Ceretrieve Ltd Company Overview 41
  • 5.13 Cerus Endovascular Ltd Company Overview 42
  • 5.14 Codman & Shurtleff Inc Company Overview 46
  • 5.15 Collagen Matrix Inc Company Overview 49
  • 5.16 CranioVation Company Overview 50
  • 5.17 CVTec Cerebrovascular Technologies GmbH Company Overview 51
  • 5.18 Dartmouth College Company Overview 52
  • 5.19 DePuy Synthes Inc Company Overview 54
  • 5.20 EchoGuide Medical, Inc. (Inactive) Company Overview 55
  • 5.21 Ecole Polytechnique Federale de Lausanne Company Overview 56
  • 5.22 Evasc Medical Systems Corp Company Overview 57
  • 5.23 Gaudi Vascular, Inc. Company Overview 60
  • 5.24 Hansen Medical Inc Company Overview 61
  • 5.25 Hibernia Medical Company Overview 62
  • 5.26 Insera Therapeutics, LLC Company Overview 63
  • 5.27 InspireMD Inc Company Overview 64
  • 5.28 Instent SAS Company Overview 65
  • 5.29 Medikit Co Ltd Company Overview 66
  • 5.30 Medtronic plc Company Overview 69
  • 5.31 Merlin MD Pte. Ltd. Company Overview 75
  • 5.32 Metactive Medical LLC Company Overview 76
  • 5.33 MicroPort Scientific Corp Company Overview 77
  • 5.34 MicroVention Inc Company Overview 82
  • 5.35 MindFrame Inc Company Overview 92
  • 5.36 MRI Interventions Inc Company Overview 93
  • 5.37 NEOS Surgery SL Company Overview 94
  • 5.38 Neuravi Ltd Company Overview 96
  • 5.39 NeuroInterventional Therapeutics, Inc. Company Overview 98
  • 5.40 NeuroInterventions Company Overview 99
  • 5.41 Neurosigma Inc Company Overview 100
  • 5.42 Neurosyntec LLC. (Inactive) Company Overview 101
  • 5.43 NexGen Medical Systems Inc Company Overview 102
  • 5.44 Novasentis Inc Company Overview 103
  • 5.45 NSVascular, Inc. Company Overview 104
  • 5.46 Oxford Endovascular Ltd Company Overview 105
  • 5.47 Palmaz Scientific Inc (Inactive) Company Overview 106
  • 5.48 PhotoThera Inc (Inactive) Company Overview 107
  • 5.49 Pulse Therapeutics Inc Company Overview 112
  • 5.50 Qvanteq AG Company Overview 115
  • 5.51 Rapid Medical Company Overview 116
  • 5.52 Rontis AG Company Overview 122
  • 5.53 Shape Memory Therapeutics, Inc. Company Overview 123
  • 5.54 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 124
  • 5.55 Stryker Corp Company Overview 125
  • 5.56 Taewoong Medical Co Ltd Company Overview 128
  • 5.57 Transverse Medical Inc Company Overview 129
  • 5.58 Triticum Medical Ltd. Company Overview 130
  • 5.59 Twin Star Medical Inc Company Overview 131
  • 5.60 University of California Los Angeles Company Overview 132
  • 5.61 University of California San Francisco Company Overview 135
  • 5.62 University of Minnesota Company Overview 136
  • 5.63 University of South Florida Company Overview 137
  • 5.64 University of Wisconsin Madison Company Overview 138
  • 5.65 University of Wolverhampton Company Overview 140
  • 5.66 Vascular Solutions Inc Company Overview 141
  • 5.67 Viket Medical Corporation Company Overview 142
  • 5.68 Voyager Therapeutics, Inc. Company Overview 143
  • 5.69 Weill Cornell Medical College Company Overview 144
  • 5.70 Zoll Medical Corporation Company Overview 145

6 Interventional Neurology Devices- Recent Developments 146

  • 6.1 May 16, 2018: Rapid Medical: First Patient Enrolled to the TIGER Pivotal Clinical Study 146
  • 6.2 May 15, 2018: BTG: Final Results For year ended 31 March 2018 146
  • 6.3 May 15, 2018: MRI Interventions Announces First Quarter 2018 Results 153
  • 6.4 May 14, 2018: Parker Waichman is Investigating Potential Neurovascular Stent Claims Following Recent FDA Safety Alert 155
  • 6.5 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 156
  • 6.6 May 10, 2018: Voyager Therapeutics Announces First Quarter 2018 Financial Results and Corporate Highlights 156
  • 6.7 May 08, 2018: Penumbra Reports First Quarter 2018 Financial Results 158
  • 6.8 May 07, 2018: Stryker''s Trevo Retriever becomes first and only device indicated for acute ischemic stroke treatment up to 24 hours in Europe 158
  • 6.9 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 159
  • 6.10 Apr 30, 2018: AxoGen Announces 2018 First Quarter Financial Results 160
  • 6.11 Apr 26, 2018: Stryker reports first quarter 2018 operating results 161
  • 6.12 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results 162
  • 6.13 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 162
  • 6.14 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 164
  • 6.15 Apr 17, 2018: Johnson & Johnson Reports 2018 First-Quarter Results 165
  • 6.16 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 167
  • 6.17 Mar 29, 2018: MicroPort Vertebral Artery Rapamycin Target Eluting Stent System Granted CFDA Green-Path 168
  • 6.18 Mar 29, 2018: MIVI Neuroscience Begins European Commercialization After Achieving CE Mark Approval Of The R4Q Revascularization Catheter For Ischemic Stroke 168
  • 6.19 Mar 28, 2018: Tubridge Gains CFDA Approval 169
  • 6.20 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 170
  • 6.21 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 171
  • 6.22 Mar 26, 2018: Silk Road Medical Names Donald J. Zurbay to Board of Directors 172
  • 6.23 Mar 21, 2018: Collagen Matrix Names Gregory Pomrink as Vice President, Research and Development 172
  • 6.24 Mar 20, 2018: Balt USA Announces 510(k) Clearance of the Optima Coil System and New Balt USA Headquarters 173
  • 6.25 Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson 173
  • 6.26 Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales 174
  • 6.27 Mar 14, 2018: Voyager Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results 177
  • 6.28 Mar 12, 2018: Neurovascular Embolization Coils and the Potential for Increased Image Artifact When Using Magnetic Resonance Angiography for Follow-Up - Letter to Health Care Providers 179
  • 6.29 Feb 28, 2018: AxoGen Reports 2017 Fourth Quarter and Full Year Financial Results 180
  • 6.30 Feb 28, 2018: Nexstim Financial Statements Release 2017 182
  • 6.31 Feb 27, 2018: Baylor St. Luke's Medical Center First in Texas to Offer PulseRider Technology for Minimally Invasive Treatment of Complex Brain Aneurysms 184
  • 6.32 Feb 27, 2018: Penumbra Reports Fourth Quarter and Full Year 2017 Financial Results 184
  • 6.33 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017 186
  • 6.34 Feb 15, 2018: FDA expands treatment window for use of clot retrieval devices in certain stroke patients 186
  • 6.35 Feb 15, 2018: Stryker's Trevo Retriever becomes first and only device indicated for treatment up to 24 hours, aligning with new AHA/ASA guidelines 187
  • 6.36 Feb 13, 2018: International Publications Validate Cog state Technology's Clinical Value in Detecting Postoperative Cognitive Dysfunction (POCD) 188
  • 6.37 Feb 13, 2018: Quidel Receives 510(k) Clearance for QuickVue Influenza A+B Test, Assay Meets FDA's Class II RIDT Requirements 189
  • 6.38 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 190
  • 6.39 Feb 07, 2018: NICE Publishes Technology Appraisal Guidance About Intrabeam Radiotherapy System for Adjuvant Treatment of Early Breast Cancer 190
  • 6.40 Feb 06, 2018: Waterpik Releases New Whitening Water Flosser 192
  • 6.41 Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017 193
  • 6.42 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 194
  • 6.43 Jan 31, 2018: Voyager Therapeutics Announces CEO Succession Plan for 2018 196
  • 6.44 Jan 30, 2018: Endocuff Vision Significantly Improves Adenoma Detection Rate and Colorectal Cancer Detection During Colonoscopy in Bowel Cancer Screening Patients 196
  • 6.45 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 197
  • 6.46 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook 198
  • 6.47 Jan 26, 2018: Stryker's WEAVE Trial demonstrates positive results of endovascular treatment for patients with intracranial atherosclerotic disease 200
  • 6.48 Jan 25, 2018: Aspiration First Approach with Penumbra System Demonstrates Favorable Outcomes for Acute Ischemic Stroke 201
  • 6.49 Jan 25, 2018: Independent Study Reaffirms Penumbra Aspiration as Frontline Thrombectomy Approach for Acute Ischemic Stroke 202
  • 6.50 Jan 25, 2018: Stryker's DAWN Trial results contribute to updated acute ischemic stroke guidelines from the American Heart Association and American Stroke Association 203
  • 6.51 Jan 25, 2018: New Study Shows Use Of EMBOTRAP Device Clot Retriever During Treatment Of Stroke Yields Positive Rates Of Revascularization 204
  • 6.52 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 205
  • 6.53 Jan 24, 2018: MRI Interventions Recognizes FDA Clearance of Voyager's Investigational New Drug Application for VY-AADC Allowing its Pivotal Program to Begin for Advanced Parkinson's Disease 207
  • 6.54 Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results 207
  • 6.55 Jan 19, 2018: School of Engineering awarded two ERC Consolidator Grants 210
  • 6.56 Jan 17, 2018: Penumbra Announces Key Events at International Stroke Conference 2018 Meeting 211
  • 6.57 Jan 11, 2018: Andover will lose nearly 2,000 jobs with Philips move 212
  • 6.58 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 212
  • 6.59 Jan 09, 2018: Stryker provides 2017 preliminary net sales results 212
  • 6.60 Jan 08, 2018: MicroPort NeuroTech Attends CINS 2017 213
  • 6.61 Jan 08, 2018: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue 214
  • 6.62 Jan 03, 2018: MRI Interventions ClearPoint Neuro Navigation System Utilized for the First Time in Minnesota 214

7 Appendix 302

  • 7.1 Methodology 302
  • 7.2 About GlobalData 305
  • 7.3 Contact Us 305
  • 7.4 Disclaimer 305
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research